Jakub Tolar

United States of America, Czech Republic

Jakub Tolar, MD, PhD, is the dean of the University of Minnesota Medical School and a Distinguished McKnight University Professor. He is also the vice president for Clinical Affairs at the University of Minnesota, board chair for University of Minnesota Physicians and co-leader of M Health Fairview, the joint clinical enterprise among the University of Minnesota Medical School, University of Minnesota Physicians and Fairview Health Services. An internationally recognized physician and researcher, Dr. Tolar is known for advances in blood and marrow transplantation, especially in treatment of stem cell failure syndromes (such as, Fanconi anemia and dyskeratosis congenita), metabolic disorders (such as, mucopolysaccharidosis type I and adrenoleukodystrophy), and connective tissue disorders (such as, epidermolysis bullosa). His research has been focused on developing genomic and cellular therapies for these rare disorders. Originally from the Czech Republic, Dr. Tolar received his medical education (MD) in Prague at Charles University. In 1992, he came to the University of Minnesota, where he received his PhD in Molecular, Cellular & Developmental Biology and Genetics.

A proposal to grant an honorary degree of Doctor Honoris Causa in the field of Medical Sciences was submitted by the Faculty of Medicine of Masaryk University. The graduation ceremony was held on 19 March 2026. A brochure introducing the nominee was issued on the occasion of the awarding of this honorary doctorate.